Naloxone Recall—Two Lots From Hospira Recalled Due to Particulate Matter

Having trouble viewing this email? View it in your browser.

Bookmark and Share

Substance Abuse and Mental Health Services Administration

Naloxone RecallTwo Lots From Hospira Recalled Due to Particulate Matter

The Food and Drug Administration (FDA) is urging Naloxone carriers to check their product against a national recall list. The maker of the drug, Hospira, has issued a voluntary recall of the opioid overdose reversal drug Naloxone due to the presence of loose particulate matter in the syringe plunger. Please inform the healthcare professionals in your network immediately. The FDA includes information on the specific product lot numbers affected by this recall.

Visit FDA Recall Webpage